STEM
Dani Heywood is a seasoned executive in the life sciences sector, currently serving as Chief Operating Officer at STEM since August 2024, where the focus is on optimizing brand strategy and execution for life science companies. Prior to this role, Dani held the position of President at KMK Consulting Inc. from January 2022 to July 2024, empowering clients to leverage data for enhanced decision-making. Dani also served as President of Branding Science, a consultancy specializing in healthcare market research, from October 2011 to January 2022, and previously as Director of the US office at Adelphi International Research, focusing on pharmaceutical market research. Dani's career began as a Research Scientist at Unilever, where expertise in biochemistry was applied in the hair care division. Educational background includes a PhD in Molecular Biology from the University of Leeds, obtained between 1991 and 1997.
This person is not in any teams
This person is not in any offices
STEM
STEM is part of Inizio Advisory, a trusted advisor for pharmaceutical, life science and healthcare companies at every stage of the product and patient journey. Through Advisory’s data driven approach and connected intelligence and solutions, Inizio Advisory helps accelerate clinical and commercial success, creating long term value for clients and their patients. Since 2007, STEM has been helping life science companies optimize the commercial performance by measuring the alignment between their brand strategy and execution at every stage of the product stage of the product lifecycle. We do this through our objective industry insights, robust benchmarking data, and a proven methodology, helping clients to improve return on investment, drive greater customer engagement, accelerate their brands performance and ensure world-class medicines reach the right patients.